Head-to-head
Compare up to 5 funds side-by-side.
Prices normalised to ₹100 at the start of the range. Metrics marked with a highlight the winner per row. Descriptive comparison only — MF Gyan does not recommend one over another.
₹1 lakh over time
What ₹1,00,000 invested at the start of each window would have become in each fund.
sectorDirect
Nippon India Pharma Fund - Direct Plan - Growth Option
3Y ago₹1.72 L
5Y ago₹1.91 L
Every metric, side-by-side
marks the winner per row.
| Metric | Nippon India Pharma Fund - Dire… |
|---|---|
| Fund house | Nippon India Mutual Fund |
| Category | Equity Schemes - Sectoral Fund |
| Plan | Direct |
| Latest NAV | ₹647.5641 |
| Assets managed (AUM) | — |
| 1M return | 1.12% |
| 6M return | 12.24% |
| 1Y return | 14.06% |
| 3Y CAGR | 19.72% |
| 5Y CAGR | 13.85% |
| Since inception CAGR | 17.70% |
| Bumpiness · 3Y (annualised σ) | 12.97 |
| Worst drop ever | -24.02% |
| Sharpe · 3Y (rf=6%) | 0.96 |